[1]
Atkinson MD, Brophy S, Siebert S, Gravenor MB, Phillips C, Ford DV, Jones KH, Lyons RA. Protocol for a population-based ankylosing spondylitis (PAS) cohort in Wales. BMC musculoskeletal disorders. 2010 Sep 1:11():197. doi: 10.1186/1471-2474-11-197. Epub 2010 Sep 1
[PubMed PMID: 20809952]
[2]
Macfarlane GJ, MacDonald RIR, Pathan E, Siebert S, Gaffney K, Choy E, Packham J, Martin KR, Haywood K, Sengupta R, Atzeni F, Jones GT. Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register. Rheumatology (Oxford, England). 2018 Nov 1:57(11):1982-1990. doi: 10.1093/rheumatology/key206. Epub
[PubMed PMID: 30053166]
[3]
Barczyńska TA, Węgierska M, Żuchowski P, Dura M, Zalewska J, Waszczak M, Jeka S. Coexistence of rheumatoid arthritis and ankylosing spondylitis. Reumatologia. 2015:53(5):279-85. doi: 10.5114/reum.2015.55832. Epub 2015 Dec 8
[PubMed PMID: 27407260]
[4]
Aradoini N,Talbi S,Azzouzi H,Abourazzak FZ,Khibri H,Berrady R,Bono W,Harzy T, [Ankylosing spondylitis associated with Still's disease: should it be considered a pathophysiologic link or a simple association?] The Pan African medical journal. 2017
[PubMed PMID: 29515750]
[5]
Ortega Castro R, Font Ugalde P, Castro Villegas MC, Calvo Gutiérrez J, Muñoz Gomariz E, Zarco Montejo P, Almodóvar R, Mulero Mendoza J, Torre-Alonso JC, Gratacós Masmitjá J, Juanola Roura X, Ariza Ariza R, Fernández Dapica P, Linares Ferrando LF, Brito Brito ME, Cuende Quintana E, Vázquez Galeano C, Moreno Ramos MJ, Giménez Úbeda E, Rodríguez Lozano JC, Fernández Prada M, Queiro Silva R, Moreno Ruzafa E, Júdez Navarro E, Más AJ, Medrano Le Quement C, Ornilla E, Montilla Morales C, Pujol Busquets M, Clavaguera Poch T, Fernández-Espartero MC, Carmona Ortell L, Collantes Estévez E. Different clinical expression of patients with ankylosing spondylitis according to gender in relation to time since onset of disease. Data from REGISPONSER. Reumatologia clinica. 2013 Jul-Aug:9(4):221-5. doi: 10.1016/j.reuma.2012.09.008. Epub 2013 Mar 7
[PubMed PMID: 23474378]
[6]
Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint bone spine. 2008 May:75(3):291-4. doi: 10.1016/j.jbspin.2007.06.016. Epub 2008 Apr 9
[PubMed PMID: 18403245]
[7]
Layh-Schmitt G, Lu S, Navid F, Brooks SR, Lazowick E, Davis KM, Montagna C, Gadina M, Colbert RA. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors. Clinical rheumatology. 2017 Jan:36(1):143-154. doi: 10.1007/s10067-016-3469-5. Epub 2016 Nov 18
[PubMed PMID: 27864696]
[8]
Matei C, Moise A, Suţeanu S. [An association between ankylosing spondylitis and rheumatoid polyarthritis; comments on 3 cases]. Medicina interna (Bucharest, Romania : 1991). 1992:44(2-4):61-5
[PubMed PMID: 1345061]
Level 3 (low-level) evidence
[9]
Smith JA, Update on ankylosing spondylitis: current concepts in pathogenesis. Current allergy and asthma reports. 2015 Jan
[PubMed PMID: 25447326]
[11]
Taurog JD, Chhabra A, Colbert RA. Ankylosing Spondylitis and Axial Spondyloarthritis. The New England journal of medicine. 2016 Sep 29:375(13):1303. doi: 10.1056/NEJMc1609622. Epub
[PubMed PMID: 27682050]
[12]
Caporali R, Zavaglia D. Real-world experience with tofacitinib for the treatment of rheumatoid arthritis. Clinical and experimental rheumatology. 2019 May-Jun:37(3):485-495
[PubMed PMID: 30183607]
[13]
Nannapaneni R, Behari S, Todd NV. Surgical outcome in rheumatoid Ranawat Class IIIb myelopathy. Neurosurgery. 2005 Apr:56(4):706-15; discussion 706-15
[PubMed PMID: 15792509]
[14]
Weber U, Hodler J, Kubik RA, Rufibach K, Lambert RG, Kissling RO, Pfirrmann CW, Maksymowych WP. Sensitivity and specificity of spinal inflammatory lesions assessed by whole-body magnetic resonance imaging in patients with ankylosing spondylitis or recent-onset inflammatory back pain. Arthritis and rheumatism. 2009 Jul 15:61(7):900-8. doi: 10.1002/art.24507. Epub
[PubMed PMID: 19565558]
[18]
Şahin A, Yetişgin A, Şahin M, Durmaz Y, Cengiz AK. Can Mean Platelet Volume Be a Surrogate Marker of Inflammation in Rheumatic Diseases? The West Indian medical journal. 2015 May 6:65(1):165-169. doi: 10.7727/wimj.2014.202. Epub 2015 May 6
[PubMed PMID: 26645595]
[19]
Kim NR, Choi JY, Hong SH, Jun WS, Lee JW, Choi JA, Kang HS. "MR corner sign": value for predicting presence of ankylosing spondylitis. AJR. American journal of roentgenology. 2008 Jul:191(1):124-8. doi: 10.2214/AJR.07.3378. Epub
[PubMed PMID: 18562734]
[20]
Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis & rheumatology (Hoboken, N.J.). 2016 Feb:68(2):282-98. doi: 10.1002/art.39298. Epub 2015 Sep 24
[PubMed PMID: 26401991]
[21]
Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, van Tubergen A. Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Annals of the rheumatic diseases. 2016 Jan:75(1):203-9. doi: 10.1136/annrheumdis-2014-206147. Epub 2014 Oct 31
[PubMed PMID: 25362044]
[22]
Schieir O, Tosevski C, Glazier RH, Hogg-Johnson S, Badley EM. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis. Annals of the rheumatic diseases. 2017 Aug:76(8):1396-1404. doi: 10.1136/annrheumdis-2016-210275. Epub 2017 Feb 20
[PubMed PMID: 28219882]
Level 1 (high-level) evidence
[23]
Lee JL, Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Arthritis research & therapy. 2018 Aug 7:20(1):171. doi: 10.1186/s13075-018-1669-x. Epub 2018 Aug 7
[PubMed PMID: 30086795]